New data shows stable symptoms when switching from atypical antipsychotics to Cobenfy using cross-titration.
Harald Hampel, MD, PhD, MSc
Advertisement
Articles by Harald Hampel, MD, PhD, MSc
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Vol 43, Issue 9 - Interactive
2
FDA Hearing on Psychedelic Medicine Reveals a Field Divided on the Road to Approval
3
New Adult ADHD Guidelines: What Resources Are Coming Soon
4
Insights on the New Adult ADHD Guidelines: A Conversation With the President of APSARD
5